NUVAXOVID

This brand name is authorized in Austria, Australia, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Japan, Lithuania, New Zealand, Poland, Romania, United Kingdom

Active ingredients

The drug NUVAXOVID contains one active pharmaceutical ingredient (API):

1 SARS-CoV-2 protein subunit vaccine (NVX-CoV2373) UNII UK9AK2IN1P - NVX-COV2373

SARS-CoV-2 protein subunit vaccine (NVX-CoV2373) is composed of purified full-length SARS-CoV-2 recombinant spike (S) protein that is stabilised in its prefusion conformation. The addition of the saponin-based Matrix-M adjuvant facilitates activation of the cells of the innate immune system, which enhances the magnitude of the S protein-specific immune response. The two vaccine components elicit B- and T-cell immune responses to the S protein, including neutralising antibodies, which may contribute to protection against COVID-19. Read about SARS-CoV-2 protein subunit vaccine (NVX-CoV2373)

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NUVAXOVID Dispersion for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BN04		J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BN Covid-19 vaccines
Discover more medicines within J07BN04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1868081
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1211618001, 1211618008
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 152354
Country: FR	Base de données publique des médicaments	Identifier(s): 65689785, 69544189
Country: IT	Agenzia del Farmaco	Identifier(s): 049811019, 049811021, 049811033, 049811045, 050926017, 050926029
Country: JP	医薬品医療機器総合機構	Identifier(s): 631341GA1029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1093886, 1096834, 1097303, 1097304, 1098021, 1098022
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 22259
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100462131
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68339001